From Discovery to Delivery: Bringing Universities Research to Life

Across university campuses, groundbreaking innovation happens every day. From small molecules to advanced biologics, academic labs are driving progress in chemistry, biotech, and pharmaceutical research. Yet translating those discoveries into scalable, manufacturable products remains a persistent challenge. 

The issue isn’t a lack of innovation, it’s infrastructure. 

Parimer partners with universities, research teams, and tech transfer offices to bridge the gap between early-stage discovery and development. By offering flexible, responsive support across the product development lifecycle, Parimer enables academic innovations to move from lab bench to real-world application. 

Innovation Outpaces Infrastructure 

It’s a familiar scenario: a faculty lab develops a novel compound with promising therapeutic potential. Early data is strong, a provisional patent is filed, and the university’s commercialization office begins exploring licensing or startup options. 

Then the question arises: Can this be produced at scale? 

Academic labs often aren’t equipped to produce grams or kilograms of material. Equipment, regulatory frameworks, and quality systems may be limited. On the other hand, traditional CDMOs often pass over early-stage work due to volume or budget constraints, creating a development bottleneck that delays progress and limits commercial potential. 

Bridging the Gap 

Parimer supports university-affiliated teams across all stages of translational research from early material synthesis to small-batch GMP production. With deep experience collaborating with academic stakeholders, Parimer brings technical strength and operational understanding tailored to the university environment. 

Common scenarios include: 

• Material production for animal studies or high-throughput screening 

• Preparing compounds for licensing discussions or spinout companies 

• IND-enabling process development 

• Achieving key milestones tied to grant renewals or investor interest 

Services Aligned to Academic Needs 

Parimer offers a suite of services designed specifically to support academic research teams and tech transfer initiatives: 

Early-Stage Synthesis & Route Development Support includes route optimization, purification strategies, and reproducible batch development, laying the groundwork for data collection and regulatory alignment. 

Process Scale-Up & Material Production Whether producing grams or kilograms, Parimer delivers high-quality materials without requiring enterprise-scale commitments or long lead times. 

Formulation & Analytical Method Development Development of usable product formats oral, injectable, or topical, along with robust analytical methods that hold up to regulatory review. 

IND & Preclinical Regulatory Support From documentation to compliance, Parimer assists academic teams navigating regulatory pathways for the first time with clear, collaborative guidance. 

Pilot GMP Manufacturing When GMP-grade material is required, Parimer’s quality systems and experienced team help ensure smooth transitions into IND-enabling or clinical work. 

A Model Designed for Universities 

Parimer was built with early-stage innovators in mind, not enterprise-scale pharmaceutical contracts. Its approach is tailored to the unique needs of academic and nonprofit research teams. 

Right-Sized Operations Smaller projects are welcomed, not deprioritized. Each engagement receives expert attention, no matter the scale. 

Direct Communication Parimer’s team includes scientists and project leads who communicate clearly, regularly, and without unnecessary jargon. 

Flexible Structures Budgets, timelines, and scope are developed in alignment with grant cycles, SBIR guidelines, and university processes. 

Deep Understanding of Academic Culture Team members have worked in university labs and understand the pressures of publication, collaboration, and IP protection. 

Real-World Impact 

Parimer has supported a range of university-affiliated initiatives, including: 

• Scaling production of an anti-inflammatory compound for NIH-funded animal studies 

• Developing a stable injectable formulation to support tech transfer licensing conversations 

• Producing pilot batches of a targeted cancer therapy for preclinical evaluation 

• Building analytical methods and regulatory documentation for a startup rooted in academic research 

  
  

Collaboration Without Compromise 

University-based work comes with unique requirements and more stakeholders, careful documentation, and collaborative oversight. Parimer is structured to work within these frameworks. 

That includes: 

• Clear IP and publication rights alignment 

• Coordination with tech transfer and sponsored research offices 

• Support for MTAs, service agreements, and hybrid engagement models 

• Transparent pricing and timelines 

• Documentation support for grant submissions or renewals 

Empowering the Transition from Lab to Market 

From principal investigators to commercialization teams, Parimer offers the scientific and operational expertise needed to turn promising research into deliverable solutions.